Sector valuations GC Genome Corporation
Stocks
A340450
KR7340450006
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,730.00 KRW | +2.38% |
|
+4.53% | -30.65% |
| Dec. 09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 25-06-12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.35x | - | 13.12x | - | 75.52M | ||
| -162x | 20.45x | -16.91x | 13.44x | -183x | -147.76x | -.--% | 38.64B | ||
| 19.43x | 2.45x | 0.5x | 1.89x | 10.86x | 12.82x | 1.03% | 23.12B | ||
| 17.48x | 1.23x | 1.06x | 1.35x | 7.7x | 14.08x | 4.99% | 7.52B | ||
| 323.03x | - | -1.81x | - | - | - | - | 4.95B | ||
| 49.18x | 10.23x | 3.09x | 8.75x | 31.09x | 38.8x | 1.06% | 3B | ||
| -18.44x | - | -0.05x | - | - | - | - | 1.83B | ||
| 36.14x | 1.86x | -0.12x | 1.71x | 13.57x | 22.47x | 1.41% | 1.91B | ||
| -33.3x | - | 0.71x | - | - | - | -.--% | 1.93B | ||
| 33.22x | 1.95x | 0.04x | 1.19x | 9.94x | 14.5x | 0.76% | 1.91B | ||
| 12.91x | 1.72x | 0.95x | 1.34x | 5.23x | 8.92x | 5.86% | 1.75B | ||
| 84.83x | 15.24x | 4.33x | 17.68x | 43.65x | 59.51x | 0.12% | 1.51B | ||
| 59.93x | 8.26x | 1.61x | 7.18x | 29.61x | 42.81x | 0.35% | 1.24B | ||
| 32.74x | 1.38x | -2.13x | 0.8x | 6.66x | 22.79x | 3.71% | 1.14B | ||
| -3.93x | 0.52x | -3.94x | 0.95x | - | -2.4x | - | 899M | ||
| 42.75x | 13.15x | 2.09x | - | - | - | 2.04% | 871M | ||
| 18.11x | 1.04x | -14.24x | - | - | - | 3.43% | 840M | ||
| 26.93x | 2.02x | 1.05x | - | - | - | 0.36% | 829M | ||
| -44.2x | - | 1.48x | 187.26x | -40.84x | -38.78x | - | 616M | ||
| Average | 27.49x | 5.82x | -1.24x | 18.84x | -5.96x | 4.68x | 1.8% | 4.98B | |
| Weighted average by Cap. | -37.99x | 11.11x | -6.74x | 9.12x | -79.28x | -59.53x | 1.03% |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















